Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
Current Issues in Molecular Biology
|
September 22, 2022
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study
Alberto D'Angelo, Fabiola Giudici, Robert Chapman, et al.
Scientific Reports
|
November 7, 2020
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer
Giandomenico Roviello, Monica Ramello, Martina Catalano, et al.
Cancer Immunology, Immunotherapy : CII
|
December 18, 2025
Immune biomarkers for head and neck cancer
Navid Sobhani, Alberto D'Angelo, Fernanda G Kugeratski, et al.
Asian Journal of Urology
|
March 21, 2023
Robotic approach with neoadjuvant chemotherapy in adult Wilms' tumor: A feasibility study report and a systematic review of the literature
Simone Sforza, Valeria Emma Palmieri, Maria Rosaria Raspollini, et al.
Biomedicines
|
February 25, 2023
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report
Navid Sobhani, Victoria Bouchè, Giovanni Aldegheri, et al.
Genes
|
January 25, 2025
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies
Giandomenico Roviello, Irene De Gennaro, Ismaela Vascotto, et al.
Plos One
|
January 17, 2023
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses
Alberto D'Angelo, Huseyin Kilili, Robert Chapman, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
Current Issues in Molecular Biology
|
September 22, 2022
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study
Alberto D'Angelo, Fabiola Giudici, Robert Chapman, et al.
Scientific Reports
|
November 7, 2020
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer
Giandomenico Roviello, Monica Ramello, Martina Catalano, et al.
Cancer Immunology, Immunotherapy : CII
|
December 18, 2025
Immune biomarkers for head and neck cancer
Navid Sobhani, Alberto D'Angelo, Fernanda G Kugeratski, et al.
Asian Journal of Urology
|
March 21, 2023
Robotic approach with neoadjuvant chemotherapy in adult Wilms' tumor: A feasibility study report and a systematic review of the literature
Simone Sforza, Valeria Emma Palmieri, Maria Rosaria Raspollini, et al.
Biomedicines
|
February 25, 2023
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report
Navid Sobhani, Victoria Bouchè, Giovanni Aldegheri, et al.
Genes
|
January 25, 2025
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies
Giandomenico Roviello, Irene De Gennaro, Ismaela Vascotto, et al.
Plos One
|
January 17, 2023
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses
Alberto D'Angelo, Huseyin Kilili, Robert Chapman, et al.
Page
of 6